Gene therapy may fight AIDS
Print Edition
Scientists have modified genes in the blood cells of HIV patients to help them resist the AIDS virus, and say the treatment seems safe and promising.
The results give hope that this might one day free some people from needing medicines to keep HIV under control.
The idea came from an AIDS patient who appears cured after getting a cell transplant seven years ago in Berlin from a donor with natural immunity to HIV. Only about 1 percent of people have two copies of the gene that gives this protection.
Researchers are seeking a more practical way to get similar results by using gene therapy to modify patients’ own blood cells.
A study of this in 12 patients was led by Dr Carl June at the University of Pennsylvania. The results were in yesterday’s “New England Journal of Medicine.” These are the first published results from this method, which also has been tried in several smaller studies.
HIV usually infects blood cells through a protein on their surface called CCR5. American company Sangamo BioSciences Inc makes a treatment that can knock out a gene that makes CCR5.
The 12 HIV patients had their blood filtered to remove some of their cells. The gene-snipping compound was added and the cells put back into the patients.
Four weeks later, half of the patients were temporarily taken off AIDS medicines to see the gene therapy’s effect. The virus returned in all but one of them, but the modified cells seemed to be protected from HIV infection and were more likely to survive.
“The hope is that the modified cells eventually will outnumber the rest and give the patient a way to control viral levels without medicines, said Dr Pablo Tebas, one of the Penn researchers.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
